Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs

by Pallavi Surana, Ashwin Kumar Jainarayanan, Nithishwer Mouroug Anand, Mukta Sharma
Published 2019-12-01

A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing.

by Nithishwer Mouroug Anand, Devang Haresh Liya, Arpit Kumar Pradhan, Nitish Tayal, Abhinav Bansal, Sainitin Donakonda, Ashwin Kumar Jainarayanan
Published 2021-01-01